Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 1039-1046

  Raddassi, Khadir ^a,b   Kent, Sally C ^b,e   Yang, Junbao ^c   Bourcier, Kasia ^d   Bradshaw, Elizabeth M ^b   Seyfert Margolis, Vicki ^d   Nepom, Gerald T ^b   Kwok, William W ^b   Hafler, David A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d Tolerance Assays and Data Analysis   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TETRAMER;

ADULT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYMPHOCYTE CULTURE; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AGED; AMINO ACID SUBSTITUTION; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL LINE, TRANSFORMED; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE FREQUENCY; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN MULTIMERIZATION;

EID: 79960536431     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001543     Document Type: Article

References (53)

1. Agrawal, S. M., and V. W. Yong. 2007. Immunopathogenesis of multiple sclerosis. Int. Rev. Neurobiol. 79: 99-126.
2. Minagar, A., A. Carpenter, and J. S. Alexander. 2007. The destructive alliance: interactions of leukocytes, cerebral endothelial cells, and the immune cascade in pathogenesis of multiple sclerosis. Int. Rev. Neurobiol. 79: 1-11.
3. Peterson, J. W., and B. D. Trapp. 2005. Neuropathobiology of multiple sclerosis. Neurol. Clin. 23: 107-129, vi-vii.
4. Hafler, D. A., J. M. Slavik, D. E. Anderson, K. C. O'Connor, P. De Jager, and C. Baecher-Allan. 2005. Multiple sclerosis. Immunol. Rev. 204: 208-231.
5. Martin, R., M. D. Howell, D. Jaraquemada, M. Flerlage, J. Richert, S. Brostoff, E. O. Long, D. E. McFarlin, and H. F. McFarland. 1991. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J. Exp. Med. 173: 19-24.
6. Ota, K., M. Matsui, E. L. Milford, G. A. Mackin, H. L. Weiner, and D. A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346: 183-187.
7. Pette, M., K. Fujita, B. Kitze, J. N. Whitaker, E. Albert, L. Kappos, and H. Wekerle. 1990. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40: 1770-1776. (Pubitemid 20383149)
8. Wucherpfennig, K. W., J. Zhang, C. Witek, M. Matsui, Y. Modabber, K. Ota, and D. A. Hafler. 1994. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J. Immunol. 152: 5581-5592.
9. Lovett-Racke, A. E., J. L. Trotter, J. Lauber, P. J. Perrin, C. H. June, and M. K. Racke. 1998. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients: a marker of activated/memory T cells. J. Clin. Invest. 101: 725-730.
10. Scholz, C., K. T. Patton, D. E. Anderson, G. J. Freeman, and D. A. Hafler. 1998. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J. Immunol. 160: 1532-1538.
11. Zhang, J., S. Markovic-Plese, B. Lacet, J. Raus, H. L. Weiner, and D. A. Hafler. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179: 973-984.
12. De Jager, P. L., X. Jia, J. Wang, P. I. de Bakker, L. Ottoboni, N. T. Aggarwal, L. Piccio, S. Raychaudhuri, D. Tran, C. Aubin, et al; International MS Genetics Consortium. 2009. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41: 776-782.
13. Hafler, D. A., A. Compston, S. Sawcer, E. S. Lander, M. J. Daly, P. L. De Jager, P. I. de Bakker, S. B. Gabriel, D. B. Mirel, A. J. Ivinson, et al; International Multiple Sclerosis Genetics Consortium. 2007. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357: 851-862. (Pubitemid 47347319)
14. Jaraquemada, D., R. Martin, S. Rosen-Bronson, M. Flerlage, H. F. McFarland, and E. O. Long. 1990. HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. J. Immunol. 145: 2880-2885.
15. Wucherpfennig, K. W., A. Sette, S. Southwood, C. Oseroff, M. Matsui, J. L. Strominger, and D. A. Hafler. 1994. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 179: 279-290.
16. Bieganowska, K. D., L. J. Ausubel, Y. Modabber, E. Slovik, W. Messersmith, and D. A. Hafler. 1997. Direct ex vivo analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease. J. Exp. Med. 185: 1585-1594.
17. Hong, J., Y. C. Zang, S. Li, V. M. Rivera, and J. Z. Zhang. 2004. Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes. Eur. J. Immunol. 34: 870-881.
18. Forsthuber, T. G., C. L. Shive, W. Wienhold, K. de Graaf, E. G. Spack, R. Sublett, A. Melms, J. Kort, M. K. Racke, and R. Weissert. 2001. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. J. Immunol. 167: 7119-7125. (Pubitemid 33144209)
19. Kerlero de Rosbo, N., M. Hoffman, I. Mendel, I. Yust, J. Kaye, R. Bakimer, S. Flechter, O. Abramsky, R. Milo, A. Karni, and A. Ben-Nun. 1997. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur. J. Immunol. 27: 3059-3069.
20. Koehler, N. K., C. P. Genain, B. Giesser, and S. L. Hauser. 2002. The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study. J. Immunol. 168: 5920-5927.
21. Linington, C., T. Berger, L. Perry, S. Weerth, D. Hinze-Selch, Y. Zhang, H. C. Lu, H. Lassmann, and H. Wekerle. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23: 1364-1372.
22. + multiple sclerosis. Eur. J. Immunol. 28: 3329-3335.
23. Hafler, D. A., D. S. Benjamin, J. Burks, and H. L. Weiner. 1987. Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluidderived T cell clones in multiple sclerosis and postinfectious encephalomyelitis. J. Immunol. 139: 68-72.
24. McCutcheon, M., N. Wehner, A. Wensky, M. Kushner, S. Doan, L. Hsiao, P. Calabresi, T. Ha, T. V. Tran, K. M. Tate, et al. 1997. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. J. Immunol. Methods 210: 149-166. (Pubitemid 28266559)
25. Söderström, M., H. Link, J. B. Sun, S. Fredrikson, V. Kostulas, B. Höjeberg, B. L. Li, and T. Olsson. 1993. T cells recognizing multiple peptides of myelin basic protein are found in blood and enriched in cerebrospinal fluid in optic neuritis and multiple sclerosis. Scand. J. Immunol. 37: 355-368.
26. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer- Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
27. De Vries, I. J., M. R. Bernsen, W. L. van Geloof, N. M. Scharenborg, W. J. Lesterhuis, P. D. Rombout, G. N. Van Muijen, C. G. Figdor, C. J. Punt, D. J. Ruiter, and G. J. Adema. 2007. In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients. Cancer Immunol. Immunother. 56: 1667-1676.
28. + CTLs with HLA class I tetramers. J. Immunol. 165: 7285-7292.
29. Skowera, A., R. J. Ellis, R. Varela-Calviño, S. Arif, G. C. Huang, C. Van-Krinks, A. Zaremba, C. Rackham, J. S. Allen, T. I. Tree, et al. 2008. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucoseregulated preproinsulin epitope. J. Clin. Invest. 118: 3390-3402.
30. + T cells directed to self-antigens. Eur. J. Immunol. 33: 1409-1417.
31. + T cells in autoimmune diabetes after pancreas transplantation. Clin. Immunol. 128: 23-30.
32. Mallone, R., S. A. Kochik, H. Reijonen, B. Carson, S. F. Ziegler, W. W. Kwok, and G. T. Nepom. 2005. Functional avidity directs T-cell fate in autoreactive CD4+ T cells. Blood 106: 2798-2805.
33. + T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope. J. Autoimmun. 31: 30-41.
34. Mallone, R., and G. T. Nepom. 2005. Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes. Am. J. Ther. 12: 534-550.
35. Nepom, G. T. 2005. Tetramer analysis of human autoreactive CD4-positive T cells. Adv. Immunol. 88: 51-71.
36. + T cell epitopes from complex antigens. J. Immunol. 166: 6665-6670.
37. + T cells proliferating in response to influenza A antigen. J. Clin. Invest. 104: R63-R67.
38. high, proliferating subset. Int. Immunol. 13: 799-806.
39. Oling, V., J. Marttila, J. Ilonen, W.W. Kwok, G. Nepom, M. Knip, O. Simell, and H. Reijonen. 2005. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J. Autoimmun. 25: 235-243. (Pubitemid 41654469)
40. Reichstetter, S., R. A. Ettinger, A. W. Liu, J. A. Gebe, G. T. Nepom, and W. W. Kwok. 2000. Distinct T cell interactions with HLA class II tetramers characterize a spectrum of TCR affinities in the human antigen-specific T cell response. J. Immunol. 165: 6994-6998.
41. + T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes 53: 1987-1994.
42. Reijonen, H., E. J. Novak, S. Kochik, A. Heninger, A. W. Liu, W. W. Kwok, and G. T. Nepom. 2002. Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 51: 1375-1382.
43. Mallone, R., S. A. Kochik, E. M. Laughlin, V. H. Gersuk, H. Reijonen, W. W. Kwok, and G. T. Nepom. 2004. Differential recognition and activation thresholds in human autoreactive GAD-specific T-cells. Diabetes 53: 971-977.
44. + T cells in healthy and type 1 diabetic subjects. J. Autoimmun. 25: 303-311.
45. Reddy, J., E. Bettelli, L. Nicholson, H. Waldner, M. H. Jang, K. W. Wucherpfennig, and V. K. Kuchroo. 2003. Detection of autoreactive myelin proteolipid protein 139-151-specific T cells by using MHC II (IAs) tetramers. J. Immunol. 170: 870-877.
46. Daniels, M. A., L. Devine, J. D. Miller, J. M. Moser, A. E. Lukacher, J. D. Altman, P. B. Kavathas, K. A. Hogquist, and S. C. Jameson. 2001. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 15: 1051-1061.
47. Lindert, R. B., C. G. Haase, U. Brehm, C. Linington, H. Wekerle, and R. Hohlfeld. 1999. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Brain 122: 2089-2100.
48. Bahbouhi, B., S. Pettré, L. Berthelot, A. Garcia, A. Elong Ngono, N. Degauque, L. Michel, S. Wiertlewski, F. Lefrère, C. Meyniel, et al. 2010. T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T cells in multiple sclerosis. Brain 133: 1622-1636.
49. Jennes, W., L. Kestens, D. F. Nixon, and B. L. Shacklett. 2002. Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15: the Amplispot assay. J. Immunol. Methods 270: 99-108.
50. Bielekova, B., P. A. Muraro, L. Golestaneh, J. Pascal, H. F. McFarland, and R. Martin. 1999. Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7. J. Neuroimmunol. 100: 115-123. (Pubitemid 30038245)
51. Chou, Y. K., D. N. Bourdette, D. Barnes, T. P. Finn, S. Murray, L. Unsicker, I. Robey, R. H. Whitham, A. C. Buenafe, M. Allegretta, et al. 1999. IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R α and γ chains. J. Neuroimmunol. 96: 101-111. (Pubitemid 29179750)
52. Standifer, N. E., E. A. Burwell, V. H. Gersuk, C. J. Greenbaum, and G. T. Nepom. 2009. Changes in autoreactive T cell avidity during type 1 diabetes development. Clin. Immunol. 132: 312-320.
53. Vendrame, F., A. Pileggi, E. Laughlin, G. Allende, A. Martin-Pagola, R. D. Molano, S. Diamantopoulos, N. Standifer, K. Geubtner, B. A. Falk, et al. 2010. Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 59: 947-957.